InMed Pharmaceuticals Inc (IN):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:InMed Pharmaceuticals Inc (IN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12330
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
InMed Pharmaceuticals Inc (InMed), formerly Cannabis Technologies Inc, is a pre-clinical stage biopharmaceutical company which develops, produces and markets plant cannabinoid based medicines. The company’s pipeline products include INM-750, INM-405, and INM-085. Its products finds application in treatment of glaucoma, ocular allergies, arthritis, cancer and skin diseases, epidermolysis bullosa, psoriasis and pemphigus vulgaris metabolic syndrome, among others. InMed uses its proprietary platform technology to discover new bioactive compounds within the cannabis plant that interact with certain genes responsible for specific diseases. The company carries out research and development activities investigating the disease fighting properties of cannabis revolves around one class of biologically active ingredients. InMed is headquartered in Vancouver, British Columbia, Canada.

InMed Pharmaceuticals Inc (IN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
InMed Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
InMed Pharmaceuticals Signs Agreement with the National Research Council of Canada 13
InMed Pharma Enters into Research and Development Agreement with ATERA 14
InMed Pharma Enters into Agreement with Pharmaseed 15
Revive Therapeutics to Enter into Agreement with InMed Pharma 16
InMed Pharma Enters into Agreement with University of Debrecen to Develop Novel Phytocannabinoid Therapies for Ocular Allergies 17
InMed Pharma Enters into Agreement with University of British Columbia 18
Cannabis Science Enters into Co-Development Agreement with ImmunoClin 19
Cannabis Science Enters Into Joint Venture With Dupetit Natural Products 20
Licensing Agreements 21
Cannabis Science Enters Into Licensing Agreement With Endocan 21
Equity Offering 22
InMed Pharma Raises USD11.5 Million in Public Offering of Units 22
InMed Pharma Raises USD1.6 million in Public Offering of Shares 23
InMed Pharma Raises USD7.3 Million in Private Placement of Units 24
InMed Pharma Raises USD1 Million in Private Placement of Units 25
InMed Pharma Raises USD4.3 Million in Public Offering of Units 26
InMed Pharma Raises USD1 Million in Private Placement of Shares upon Exercise of Warrants 28
InMed Pharma Raises USD0.2 Million in Private Placement of Units 29
InMed Pharma to Raise USD0.7 Million in Private Placement of Units 30
InMed Pharma Raises USD0.83 Million in Private Placement of Units 31
InMed Pharma Raises USD0.8 Million in Private Placement of Units 32
Cannabis Science Raises USD1 Million in Private Placement of Shares 33
Asset Transactions 34
X-Change Acquires Phytiva Brand Of Products From Cannabis Science 34
Acquisition 35
Cannabis Science Acquires Additional 30.1% Stake in Michigan Green Technologies 35
Cannabis Science to Acquire Canada-Based Medical Cannabis Provider 36
X-Change Acquires Germany-Based Joint Venture Company From Cannabis Science And Dupetit Natural Products 37
Cannabis Science Acquires Trimcare, Provider Of Healthcare Facilities 38
InMed Pharmaceuticals Inc – Key Competitors 39
InMed Pharmaceuticals Inc – Key Employees 40
InMed Pharmaceuticals Inc – Locations And Subsidiaries 41
Head Office 41
Recent Developments 42
Financial Announcements 42
Sep 13, 2018: InMed Pharmaceuticals reports fourth quarter and full year fiscal 2018 financial results and provides R&D and business update 42
May 11, 2018: InMed Reports Third Quarter Fiscal 2018 Financial Results and Provides Business Update 44
Corporate Communications 46
May 04, 2018: OTC Markets Group Welcomes InMed Pharmaceuticals to OTCQX 46
May 01, 2018: InMed Names Dr. Vikramaditya G. Yadav To Scientific Advisory Board 47
Apr 11, 2018: InMed Announces Appointment of Joshua Blacher as Chief Business Officer 48
Mar 23, 2018: InMed Pharmaceuticals Announces Graduation to Toronto Stock Exchange 49
Mar 02, 2018: InMed Receives Conditional Approval to List on the Toronto Stock Exchange 50
Oct 10, 2017: InMed Appoints Dr. Mauro Maccarrone to its Scientific Advisory Board 51
Jan 13, 2017: InMed Pharmaceuticals Appoints Martin Bott to Board of Directors 52
Government and Public Interest 53
Sep 11, 2018: InMed Pharmaceuticals announces NSERC grant to The University of British Columbia in support of collaborative R&D work 53
Product News 54
Oct 24, 2017: InMed Announces Positive Pre-Clinical Data on an Ocular Hydrogel Formulation using a Biosynthesized Cannabinoid 54
07/27/2017: InMed Announces Publication in European Journal of Pain 55
Mar 06, 2018: InMed Announces Peer-Reviewed Publication in Drug Delivery and Translational Research 56
Clinical Trials 57
Oct 17, 2017: InMed Updates Pain Program 57
Appendix 58
Methodology 58
About GlobalData 58
Contact Us 58
Disclaimer 58

List of Tables
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
InMed Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
InMed Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
InMed Pharmaceuticals Signs Agreement with the National Research Council of Canada 13
InMed Pharma Enters into Research and Development Agreement with ATERA 14
InMed Pharma Enters into Agreement with Pharmaseed 15
Revive Therapeutics to Enter into Agreement with InMed Pharma 16
InMed Pharma Enters into Agreement with University of Debrecen to Develop Novel Phytocannabinoid Therapies for Ocular Allergies 17
InMed Pharma Enters into Agreement with University of British Columbia 18
Cannabis Science Enters into Co-Development Agreement with ImmunoClin 19
Cannabis Science Enters Into Joint Venture With Dupetit Natural Products 20
Cannabis Science Enters Into Licensing Agreement With Endocan 21
InMed Pharma Raises USD11.5 Million in Public Offering of Units 22
InMed Pharma Raises USD1.6 million in Public Offering of Shares 23
InMed Pharma Raises USD7.3 Million in Private Placement of Units 24
InMed Pharma Raises USD1 Million in Private Placement of Units 25
InMed Pharma Raises USD4.3 Million in Public Offering of Units 26
InMed Pharma Raises USD1 Million in Private Placement of Shares upon Exercise of Warrants 28
InMed Pharma Raises USD0.2 Million in Private Placement of Units 29
InMed Pharma to Raise USD0.7 Million in Private Placement of Units 30
InMed Pharma Raises USD0.83 Million in Private Placement of Units 31
InMed Pharma Raises USD0.8 Million in Private Placement of Units 32
Cannabis Science Raises USD1 Million in Private Placement of Shares 33
X-Change Acquires Phytiva Brand Of Products From Cannabis Science 34
Cannabis Science Acquires Additional 30.1% Stake in Michigan Green Technologies 35
Cannabis Science to Acquire Canada-Based Medical Cannabis Provider 36
X-Change Acquires Germany-Based Joint Venture Company From Cannabis Science And Dupetit Natural Products 37
Cannabis Science Acquires Trimcare, Provider Of Healthcare Facilities 38
InMed Pharmaceuticals Inc, Key Competitors 39
InMed Pharmaceuticals Inc, Key Employees 40

List of Figures
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
InMed Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[InMed Pharmaceuticals Inc (IN):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • JHL Biotech Inc (6540):企業の財務・戦略的SWOT分析
    Summary JHL Biotech Inc (JHL Biotech) is a biologic medicines provider. The company offers cell line construction, process development, manufacturing, quality and regulatory services. It offers products such as biosimilar rituximab, biosimilar dornase alfa, biosimilar bevacizumab, biosimilar trastuz …
  • Intuity Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Intuity Medical Inc (Intuity Medical), formerly Rosedale Medical is a medical device company that designs and develops medical devices to monitor diabetes. The company offers products such as POGO, an automatic blood glucose monitoring system; and Patterns, a web based data management system …
  • Civitas Solutions, Inc.:企業の戦略・SWOT・財務情報
    Civitas Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary Civitas Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • LyondellBasell Industries NV (LYB):企業の財務・戦略的SWOT分析
    LyondellBasell Industries NV (LYB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Valmieras Stikla Skiedra AS:企業の戦略・SWOT・財務情報
    Valmieras Stikla Skiedra AS - Strategy, SWOT and Corporate Finance Report Summary Valmieras Stikla Skiedra AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • IBC Solar AG:企業の戦略的SWOT分析
    IBC Solar AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Rengo Co Ltd:企業の戦略・SWOT・財務分析
    Rengo Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Rengo Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Greggs Plc:企業の戦略・SWOT・財務情報
    Greggs Plc - Strategy, SWOT and Corporate Finance Report Summary Greggs Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Tilaknagar Industries Ltd.:企業の戦略・SWOT・財務情報
    Tilaknagar Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tilaknagar Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Bank Of Panhsin
    Bank Of Panhsin - Strategy, SWOT and Corporate Finance Report Summary Bank Of Panhsin - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Hilton Worldwide Holdings Inc:企業のM&A・事業提携・投資動向
    Hilton Worldwide Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hilton Worldwide Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Engie SA:企業の戦略・SWOT・財務情報
    Engie SA - Strategy, SWOT and Corporate Finance Report Summary Engie SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Manulife Holdings Berhad:企業の戦略・SWOT・財務情報
    Manulife Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary Manulife Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Coppermoly Limited:企業の戦略・SWOT・財務情報
    Coppermoly Limited - Strategy, SWOT and Corporate Finance Report Summary Coppermoly Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cubic Corp (CUB):企業の財務・戦略的SWOT分析
    Cubic Corp (CUB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Purepoint Uranium Group Inc (PTU):企業の財務・戦略的SWOT分析
    Purepoint Uranium Group Inc (PTU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • FDC Ltd (FDC):企業の財務・戦略的SWOT分析
    Summary FDC Ltd (FDC) is a pharmaceutical company that manufactures and markets of oral rehydration salts, ophthalmics and functional foods. The company also provides active pharmaceuticals ingredients (APIs). It provides products for the therapeutic segments of anti-infectives, gastrointestinals, o …
  • Tien Phong Plastic (NTP):企業の財務・戦略的SWOT分析
    Tien Phong Plastic (NTP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • KBR Inc (KBR):企業の財務・戦略的SWOT分析
    KBR Inc (KBR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • MakeMyTrip Limited:企業のM&A・事業提携・投資動向
    MakeMyTrip Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's MakeMyTrip Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆